AS Latvijas Juras medicinas centrs (MU:UOM) — Stock Price
AS Latvijas Juras medicinas centrs (MU:UOM) is currently trading at €7.40 EUR, down 5.73% today. Over the past 52 weeks, shares have ranged between €6.40 and €9.20. This page tracks AS Latvijas Juras medicinas centrs's live share price on the MU exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see UOM market cap overview.
AS Latvijas Juras medicinas centrs (UOM) Stock Price Chart — Daily History & Trading Volume
The chart below tracks AS Latvijas Juras medicinas centrs's daily closing share price and trading volume on the MU exchange over the past year, giving a clear view of recent price momentum and liquidity.
AS Latvijas Juras medicinas centrs Income Statement — Revenue, Profit & Earnings by Year
AS Latvijas Juras medicinas centrs's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €10.29 Million | €10.19 Million | €9.85 Million | €9.70 Million | €9.36 Million |
| Cost of Revenue | €9.55 Million | €9.87 Million | €9.53 Million | €8.93 Million | €8.15 Million |
| Gross Profit | €733.85K | €319.11K | €324.15K | €774.75K | €1.22 Million |
| Research & Development | — | — | — | — | — |
| SG&A | €67.49K | €72.17K | €66.61K | €68.80K | €57.43K |
| Total Operating Expenses | €10.17 Million | €10.12 Million | €10.03 Million | €9.19 Million | €8.64 Million |
| Operating Income | €113.25K | €72.45K | €-178.49K | €507.75K | €721.20K |
| EBITDA | — | — | — | €935.63K | €1.01 Million |
| EBIT | — | — | — | €553.59K | €880.90K |
| Interest Expense | — | — | — | — | €0.00 |
| Income Before Tax | €258.28K | €185.77K | €-623.36K | €626.33K | €880.90K |
| Income Tax Expense | — | — | — | — | €645.00 |
| Net Income | €241.00K | €185.16K | €-624.25K | €625.73K | €880.26K |
AS Latvijas Juras medicinas centrs Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes AS Latvijas Juras medicinas centrs's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €8.73 Million | €9.04 Million | €9.05 Million | €8.85 Million | €8.26 Million |
| Total Current Assets | €1.58 Million | €1.45 Million | €1.27 Million | €2.44 Million | €2.31 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | €104.36K | €74.19K | €82.94K | €82.06K | €102.01K |
| Inventory | €129.56K | €133.62K | €161.51K | €143.20K | €156.52K |
| Property, Plant & Equipment | — | — | — | €6.15 Million | €5.94 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €2.40 Million | €2.88 Million | €2.85 Million | €2.04 Million | €1.92 Million |
| Total Current Liabilities | €1.83 Million | €2.16 Million | €1.86 Million | €1.27 Million | €1.29 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | €6.33 Million | €6.17 Million | €6.20 Million | €6.81 Million | €6.34 Million |
| Retained Earnings | €2.57 Million | €2.41 Million | €2.45 Million | €3.14 Million | €2.75 Million |
AS Latvijas Juras medicinas centrs Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how AS Latvijas Juras medicinas centrs generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-17.28K | €605.02K | €1.91 Million | €1.09 Million | €418.24K |
| Capital Expenditures | €190.77K | €436.21K | €2.48 Million | €629.72K | €1.11 Million |
| Free Cash Flow | €-208.05K | €168.81K | €-566.62K | €464.16K | €-691.78K |
| Investing Cash Flow | — | — | — | €-629.72K | €-1.11 Million |
| Financing Cash Flow | — | — | — | €-160.00K | €-56.00K |
| Dividends Paid | €80.00K | — | €80.00K | €160.00K | €56.00K |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €628.32K | €621.25K | €551.28K | €427.54K | €286.64K |
| Change in Cash | €308.48K | €168.81K | €-646.62K | €303.84K | €-747.78K |
AS Latvijas Juras medicinas centrs Earnings History — EPS Actual vs. Analyst Estimates
Track AS Latvijas Juras medicinas centrs's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for AS Latvijas Juras medicinas centrs.